Table 5 Distribution of IHC staining status in tumors and NATs.
From: Integrative genomics characterizes HCC eRNAs for prognosis and targeted therapy
Tumor | NAT | Total | |
|---|---|---|---|
Negative | 51 | 21 | 72 |
Positive | 9 | 39 | 48 |
Total | 60 | 60 | 120 |
From: Integrative genomics characterizes HCC eRNAs for prognosis and targeted therapy
Tumor | NAT | Total | |
|---|---|---|---|
Negative | 51 | 21 | 72 |
Positive | 9 | 39 | 48 |
Total | 60 | 60 | 120 |
